Check out and subscribe to the latest newsletter from Stevenage Bioscience Catalyst.

Highlights include: 

• UBS Asset Management and Reef Group secure approval for one of Europe's largest Life Sciences campuses in Europe
• Cell and Gene Therapy, Rentschler Biopharma and Refeyn collaborate to improve process analytical technologies and AAV manufacturing for gene therapies
• Plasticell, Cell and Gene Therapy Catapult and Imperial College London obtain funding to develop manufacturing platform for allogenic cell immunotherapies
• BioWednesday Stevenage: 6 September